跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,935 条关于
“demyelinating optic neuritis”
全部
1,935
临床试验
1,637
药物
25
机构
10
资讯
263
去年
Uveitis and Optic Neuritis Markets Set for Major Growth Through 2034 as New Therapies Advance
8个月前
FDA Grants Breakthrough Therapy Designation to Oculis' Privosegtor for Optic Neuritis Treatment
去年
Oculis' OCS-05 Shows Promise in Phase 2 Trial for Acute Optic Neuritis
去年
Oculis Strengthens Leadership with Appointment of Two World-Renowned Ophthalmology Experts as Chief Medical Advisors
去年
Bio-Thera's BAT4406F Shows Promise in Neuromyelitis Optica Spectrum Disorders
2年前
VYVGART Hytrulo Approved by FDA as First FcRn Blocker for CIDP Treatment
去年
Oculis Expands Privosegtor Development to NAION and Multiple Sclerosis Following Positive Phase 2 Results
去年
Oculis Advances Novel Therapies for Ophthalmic Diseases with Promising Pipeline Development
去年
Oculis Announces Q3 2024 Results and Pipeline Updates, Anticipates OCS-05 Phase 2 Data
去年
Oculis Price Target Increased by BofA Following Promising Phase 2 Trial Results
第 1 页，共 27 页
上一页
下一页
